Back to Journals » OncoTargets and Therapy » Volume 14

HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination Therapy

Total article views   HTML views PDF downloads Totals
6,173 Dovepress* 5,012+ 216 5,228
PubMed Central* 1,161 347 1,508
Totals 6,173 563 6,736
*Since 18 November 2021
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar